DISCO Pharmaceuticals

About DISCO Pharmaceuticals

DISCO Pharmaceuticals is a surfaceome company focused on transforming cancer care by expanding the molecular target space. Their mission is to improve patient care by unleashing the full potential of targeted cancer therapies through their transformative cell surfaceome discovery technology, which identifies surface-bound proteins and protein communities to uncover new druggable targets.

Products & Services

Surfaceome Mapping Platform:A scalable drug discovery platform that comprehensively maps the cancer cell surface to identify proteins and protein communities, enabling the development of novel cancer-selective therapies including mono-specific and bi-specific antibodies, ADCs, and T cell engagers.

Small Cell Lung Cancer (SCLC) Program:A discovery program targeting Small Cell Lung Cancer by mapping the SCLC surfaceome, identifying novel proteins and protein communities, and developing therapeutics for this tumor type with poor survival rates.

Colorectal Cancer (CRC) Program:A discovery project targeting microsatellite-stable Colorectal Cancer, mapping its surfaceome to address high unmet medical needs and develop new therapeutic options.

Specialties

Surfaceome Discovery Cancer Cell Surface Mapping Targeted Cancer Therapies Antibody Drug Conjugates (ADCs) Bi-specific Antibodies Small Cell Lung Cancer (SCLC) Colorectal Cancer (CRC)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 21900000 MR: - FA: EUR 20 Million FAN: 21900000	D: 2024-01-16 FD: 2024-01-16	4 investors

Seed Latest

2024-01-16

$21.9M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Roman Thomas

Founder & Chief Executive Officer

J

Johannes Heuckmann

Co-Founder & Chief Operating Officer

A

Ajla Hrle

Chief Business Officer

S

Stefan Ries

Chief Scientific Officer

E

Emanuela Tschudy-Milani

Vice President Technology & Head of DISCO Zürich

T

Tobias Schmidt

Vice President Discovery

View 20 more team members with Pro

Unlock Full Team Directory

Recent News